Furthermore, in high-grade NSCLC, TMB is positively correlated with TP53 and FGFR1 mutations and negatively correlated with EGFR mutations, indicating that these genes could be used to predict the TMB value in high-grade NSCLC. This evidence concerns the gene FGFR1 and non-small cell lung carcinoma.